U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of June 2016

 

Commission File Number: 001-34661

 

DEHAIER MEDICAL SYSTEMS LIMITED

 

Dehaier Medical Systems Limited

Room 501, 83 Fuxing Road

Haidian District, Beijing 100856

People’s Republic of China

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ¨

 

 

 

 

 

  

Explanatory Note:

 

On June 28, 2016, Dehaier Medical Systems Limited (the “Company”) entered into Amendment No.1 to Share Purchase Agreement (the “SPA”) with Hangzhou Liaison Interactive Information Technology Co., Ltd. (“Liaison Interactive”), a publicly listed company on the Shenzhen Stock Exchange. As previously announced, the Company entered into an SPA with Liaison Interactive. Pursuant to the SPA Liaison Interactive will invest $20 million in the Company to purchase 11,111,111 restricted common shares (the “Shares”) of the Company at a per-share price of $1.80. On June 6, 2016, the Company sold 620,414 of these shares to Liaison Interactive in a first closing under the SPA. In accordance with Amendment No.1 to SPA, the closing date is extended from June 30, 2016 to September 30, 2016.

 

The foregoing summary of the terms of Amendment No.1 to SPA is only a brief description of certain terms therein, does not purport to be a complete description of the rights and obligations of the parties thereunder, and is qualified in its entirety by reference to Amendment No.1 to SPA that is filed as Exhibit 10.2 to this Current Report on Form 6-K and incorporated herein by reference.

 

 

 

Exhibits

 

The following document is filed herewith:

 

Exhibit

Number

  Document
     
10.1   Share Purchase Agreement, dated April 28, 2016
10.2   Amendment No. 1 to Share Purchase Agreement, dated June 28, 2016

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  DEHAIER MEDICAL SYSTEMS LIMITED  
       
June 30, 2016 By:  /s/ Ping Chen  
    Ping Chen  
    Chief Executive Officer  
    (Principal Executive Officer) and  
    Duly Authorized Officer  

 

 

 

 

Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Lianluo Smart Charts.
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Lianluo Smart Charts.